Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small-Cell Lung Cancer. He J, Tsuboi M, Weder W, Chen KN, et al. J Clin Oncol 2025 Jun 2:101200JCO2500883. doi: 10.1200/JCO-25-00883.

Read + Share

Amedeo Smart

Independent Medical Education

He J, Tsuboi M, Weder W, Chen KN, et al. Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small-Cell Lung Cancer. J Clin Oncol 2025 Jun 2:101200JCO2500883. doi: 10.1200/JCO-25-00883.
PMID: 40454705